Sarepta Therapeutics, Inc.SRPTNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, structural decline.
Left:
||||
Free cash flow yield
Latest
-3.05%
↑ 54% above average
Average (9y)
-6.70%
Historical baseline
Range
High:0.19%
Low:-18.92%
CAGR
-11.8%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -3.05% | +53.8% |
| 2023 | -6.60% | -109.5% |
| 2022 | -3.15% | +52.1% |
| 2021 | -6.58% | -3562.7% |
| 2020 | 0.19% | +103.5% |
| 2019 | -5.43% | +13.3% |
| 2018 | -6.27% | +19.0% |
| 2017 | -7.74% | +59.1% |
| 2016 | -18.92% | -100.1% |
| 2015 | -9.46% | - |